Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Br J Pharmacol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    February 2018
  1. WILDER CDE, Pavlaki N, Dursun T, Gyimah P, et al
    Facilitation of ischaemia-induced ventricular fibrillation by catecholamines is mediated by beta1 and beta2 agonism in the rat heart in vitro.
    Br J Pharmacol. 2018 Feb 23. doi: 10.1111/bph.14176.
    PubMed     Text format     Abstract available


    May 2017
  2. HAGIWARA M, Shibuta S, Takada K, Kambayashi R, et al
    Unremodelled and Bradycardic Heart of the Anaesthetized Rabbit Is Applicable for Detection of Drug-induced Torsades de Pointes Arrhythmias.
    Br J Pharmacol. 2017 May 26. doi: 10.1111/bph.13870.
    PubMed     Text format     Abstract available


  3. JI Y, Varkevisser R, Opacic D, Bossu A, et al
    The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in dedicated goat and dog models.
    Br J Pharmacol. 2017 May 24. doi: 10.1111/bph.13869.
    PubMed     Text format     Abstract available


    February 2017
  4. JIE LJ, Wu WY, Li G, Xiao GS, et al
    Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells.
    Br J Pharmacol. 2017;174:254-266.
    PubMed     Text format     Abstract available


    October 2016
  5. SUGAHARA K, Maeda Y, Shimano K, Mogami A, et al
    Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.
    Br J Pharmacol. 2016 Oct 7. doi: 10.1111/bph.13641.
    PubMed     Text format     Abstract available


    May 2016
  6. BERK E, Christ T, Schwarz S, Ravens U, et al
    In permanent atrial fibrillation phosphodiesterase3 reduces force responses to 5-HT but neither PDE3 nor PDE4 influence abolished 5-HT-evoked arrhythmias.
    Br J Pharmacol. 2016 May 30. doi: 10.1111/bph.13525.
    PubMed     Text format     Abstract available


    April 2016
  7. MAJOR P, Baczko I, Hiripi L, Odening KE, et al
    A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of KCNE1 gene.
    Br J Pharmacol. 2016 Apr 14. doi: 10.1111/bph.13500.
    PubMed     Text format     Abstract available


  8. PANICKER GK, Karnad DR, Kadam P, Badilini F, et al
    Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.
    Br J Pharmacol. 2016;173:1373-80.
    PubMed     Text format     Abstract available


    February 2016
  9. CHAMPEROUX P, Le Guennec JY, Jude S, Laigot C, et al
    The high frequency relationship: implications for torsadogenic hERG blockers.
    Br J Pharmacol. 2016;173:601-12.
    PubMed     Text format     Abstract available


    January 2016
  10. LIU GZ, Hou TT, Yuan Y, Hang PZ, et al
    Fenofibrate inhibits atrial metabolic remodeling in atrial fibrillation through PPAR-alpha/Sirt1/PGC-1alpha pathway.
    Br J Pharmacol. 2016 Jan 20. doi: 10.1111/bph.13438.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: